LOS ANGELES CAPITAL MANAGEMENT LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 94 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,401,000
-16.9%
26,520
-3.5%
0.01%
-25.0%
Q2 2020$1,685,000
+136.7%
27,495
+118.6%
0.01%
+60.0%
Q1 2020$712,000
+148.1%
12,579
+165.7%
0.01%
+150.0%
Q4 2018$287,000
+1.1%
4,734
-2.6%
0.00%
+100.0%
Q3 2018$284,000
+30.3%
4,8590.0%0.00%0.0%
Q2 2018$218,000
+1.4%
4,8590.0%0.00%0.0%
Q1 2018$215,000
+1.9%
4,8590.0%0.00%0.0%
Q4 2017$211,000
-5.4%
4,859
+1.6%
0.00%0.0%
Q3 2017$223,0004,7840.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 285,259$16,685,0009.76%
JW Asset Management, LLC 73,649$4,308,0002.32%
THB ASSET MANAGEMENT 113,485$6,637,0000.81%
Eversept Partners, LP 21,900$1,280,9310.56%
EAM Global Investors LLC 20,642$1,207,0000.49%
RICE HALL JAMES & ASSOCIATES, LLC 181,690$10,627,0000.38%
Elk Creek Partners, LLC 114,230$6,681,0000.36%
ISTHMUS PARTNERS, LLC 19,525$1,142,0000.29%
PURA VIDA INVESTMENTS, LLC 20,160$1,179,0000.25%
CADENCE CAPITAL MANAGEMENT LLC 49,363$2,887,0000.16%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders